🇺🇸 FDA
Patent

US 8129334

Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory

granted A61KA61K38/00A61K38/08

Quick answer

US patent 8129334 (Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory) held by The Regents of the University of California expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/1709